Ashish M Ingle

Ashish M Ingle

UNVERIFIED PROFILE

Are you Ashish M Ingle?   Register this Author

Register author
Ashish M Ingle

Ashish M Ingle

Publications by authors named "Ashish M Ingle"

Are you Ashish M Ingle?   Register this Author

27Publications

734Reads

29Profile Views

A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112).

Clin Cancer Res 2013 Dec 4;19(23):6578-84. Epub 2013 Oct 4.

Authors' Affiliations: Texas Children's Cancer Center and Department of Pediatrics; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas; Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Children's Oncology Group, Arcadia; Geron Corporation, Menlo Park, California; Department of Oncology, Mayo Clinic, Rochester; and Department of Pediatrics, Hematology-Oncology, University of Minnesota, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079262PMC
December 2013

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Lancet Oncol 2013 May 16;14(6):472-80. Epub 2013 Apr 16.

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, and Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70095-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730818PMC
May 2013

A pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study.

Pediatr Blood Cancer 2010 Dec 13;55(7):1323-8. Epub 2010 Aug 13.

State University of New York, Health Science Center, Syracuse, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3053384PMC
December 2010

A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.

Pediatr Blood Cancer 2009 Dec;53(6):978-83

Division of Oncology, Children's National Medical Center, Washington, District of Columbia 20010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120889PMC
December 2009

Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors.

Pediatr Blood Cancer 2007 Sep;49(3):352-7

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21231-1000, and Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20753DOI Listing
September 2007